Methods	RCT.
Participants	47 women included in the analysis. Women who attended out patient clinics in 2 hospitals (Northwick Park Hospital and Aberdeen) who had bacteriuria of urine obtained through suprapubic aspiration or catheterization
Interventions	Group 1: three-day course of cephalexin 1 gram twice a day (23 women) Group 2: three-day course of pivmecillinam 200 mg and pivampicillin 250 mg (Miraxid®) twice daily (24 women)
Outcomes	Primary outcomes: Symptomatic infection: not reported. Persistent infection: group 1: 1/23; group 2: 6/24. Recurrent infection: group 1: 5/23; group 2: 4/24. Shift to another antibiotic: not reported. Adverse effects: not reported. Secondary outcomes: Preterm delivery: not reported. Preterm labor: not reported. Neonatal infection: not reported. RDS in the neonate: not reported. Admission to NICU: not reported. Duration of neonatal respiratory support: not reported.
Notes
Risk of bias
Item	Authors’ judgement	Description
Adequate sequence generation?	Unclear	Not mentioned.
Allocation concealment?	Unclear	Not mentioned.
Blinding? Participant	Yes	Described as double blind.
Blinding? Clinician	Yes	Described as double blind.
Blinding? Outcome assessor	No
Incomplete outcome data addressed? All outcomes	Yes	Follow up described as complete.
Free of selective reporting?	Yes	Planned outcome to be analyzed were all reported.
Free of other bias?	Yes